现代肿瘤医学
現代腫瘤醫學
현대종류의학
JOURNAL OF MODERN ONCOLOGY
2015年
13期
1838-1841
,共4页
张海涛%王翠翠%任凌燕%桂伟伟%冯慧
張海濤%王翠翠%任凌燕%桂偉偉%馮慧
장해도%왕취취%임릉연%계위위%풍혜
非小细胞肺癌%微小RNA-130a%Smad4%增殖
非小細胞肺癌%微小RNA-130a%Smad4%增殖
비소세포폐암%미소RNA-130a%Smad4%증식
NSCLC%microRNA-130a%Smad4%Proliferation
目的:探讨microRNA-130a(miR-130a)在非小细胞肺癌中的表达情况,并对其功能和分子机制进行研究。方法:收集50例非小细胞肺癌肿瘤组织和相对应的正常肺组织,采用 RT-PCR方法检测miR-130a的相对表达量,并分析其与临床病理资料的相关性。采用体外转染法将miR-130a抑制剂瞬时转染到A549细胞后,应用real-time PCR检测A549细胞中miR-130a的表达情况。CCK8实验检测细胞转染后的增殖变化。Western blot检测转染后细胞中Smad4的表达变化。结果:肺癌组织中miR-130a的表达水平明显高于正常肺组织( P<0.05);miR-130a的表达水平与肿瘤大小、淋巴结转移和临床分期明显相关( P<0.05)。与对照组比较,A549细胞转染miR-130a抑制剂后miR-130a表达水平明显下调,细胞增殖率明显下降,差异具有统计学意义(P<0.05);转染miR-130a抑制剂后,肺癌细胞中Smad4的表达水平明显上调。结论:miR-130a在NSCLC组织中表达上调,可能部分通过下调Smad4的表达来促进肺癌细胞的增殖和转移。
目的:探討microRNA-130a(miR-130a)在非小細胞肺癌中的錶達情況,併對其功能和分子機製進行研究。方法:收集50例非小細胞肺癌腫瘤組織和相對應的正常肺組織,採用 RT-PCR方法檢測miR-130a的相對錶達量,併分析其與臨床病理資料的相關性。採用體外轉染法將miR-130a抑製劑瞬時轉染到A549細胞後,應用real-time PCR檢測A549細胞中miR-130a的錶達情況。CCK8實驗檢測細胞轉染後的增殖變化。Western blot檢測轉染後細胞中Smad4的錶達變化。結果:肺癌組織中miR-130a的錶達水平明顯高于正常肺組織( P<0.05);miR-130a的錶達水平與腫瘤大小、淋巴結轉移和臨床分期明顯相關( P<0.05)。與對照組比較,A549細胞轉染miR-130a抑製劑後miR-130a錶達水平明顯下調,細胞增殖率明顯下降,差異具有統計學意義(P<0.05);轉染miR-130a抑製劑後,肺癌細胞中Smad4的錶達水平明顯上調。結論:miR-130a在NSCLC組織中錶達上調,可能部分通過下調Smad4的錶達來促進肺癌細胞的增殖和轉移。
목적:탐토microRNA-130a(miR-130a)재비소세포폐암중적표체정황,병대기공능화분자궤제진행연구。방법:수집50례비소세포폐암종류조직화상대응적정상폐조직,채용 RT-PCR방법검측miR-130a적상대표체량,병분석기여림상병리자료적상관성。채용체외전염법장miR-130a억제제순시전염도A549세포후,응용real-time PCR검측A549세포중miR-130a적표체정황。CCK8실험검측세포전염후적증식변화。Western blot검측전염후세포중Smad4적표체변화。결과:폐암조직중miR-130a적표체수평명현고우정상폐조직( P<0.05);miR-130a적표체수평여종류대소、림파결전이화림상분기명현상관( P<0.05)。여대조조비교,A549세포전염miR-130a억제제후miR-130a표체수평명현하조,세포증식솔명현하강,차이구유통계학의의(P<0.05);전염miR-130a억제제후,폐암세포중Smad4적표체수평명현상조。결론:miR-130a재NSCLC조직중표체상조,가능부분통과하조Smad4적표체래촉진폐암세포적증식화전이。
Objective:To investigate the exPression of miR-130a in Patients with non-small cell lung cancer (NSCLC)and to analyze the function and mechanism of miR-130a. Methods:The exPression levels of miR-130a in 50 tumor tissues and Paired normal tissues of NSCLC were detected by using RT-PCR. The relationshiP between the level of miR-130a and the Pathological characteristics was analyzed. miR-130a in vitro was transiently trans-ferred into A549 cells. The exPression level of miR-130a in A549 cells was detected by RT-PCR. Cell viability was analyzed by CCK8 assay. ExPression of Smad4 Protein was detected by Western blot. Results:The exPression level of miR-130a was uP-regulated in tumor tissues as comPared with normal lung tissues(P<0. 05). The exPression of miR-130a was associated with tumor size,lymPhatic metastasis,and TNM stages(P<0. 05). miR-130a in anti-miR-130a-transfected A549 cells was significantly decreased comPared with the control grouP(P<0. 05). The Proliferation of anti-miR-130a-transfected A549 cells was inhibited significantly. The exPression level of Smad4 was markedly uP-regulated after transfection(P<0. 05). Conclusion:The exPression of miR-130a was uP-regu-lated in NSCLC,miR-130a might Promote Proliferation and metastasis of lung cancer in Part by down-regulating the exPression of Smad4.